ONCOMED PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 9651
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 90165
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 25181
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 22145
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2079
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13112
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 990
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 742
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2105

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0296,658 Compositions and Methods for Treating and Diagnosing CancerFeb 24, 17Oct 19, 17[A61K, C07K]
2017/0298,143 RSPO BINDING AGENTS AND USES THEREOFApr 05, 17Oct 19, 17[A61K, G01N, C07K]
2017/0299,598 Methods and Monitoring of Treatment With A DLL4 AntagonistFeb 01, 17Oct 19, 17[A61K, G01N, C07K]
2017/0266,276 Combination Therapy For Treatment of CancerDec 02, 15Sep 21, 17[A61K]
2017/0267,758 IMMUNOTHERAPY WITH BINDING AGENTSMay 13, 15Sep 21, 17[C07K]
2017/0267,776 RSPO3 Binding Agents and Uses ThereofFeb 22, 17Sep 21, 17[A61K, C12Q, C07K]
2017/0247,437 RSPO1 BINDING AGENTS AND USES THEREOFAug 14, 15Aug 31, 17[A61K, C12Q, C07K]
2017/0247,465 COMBINATION THERAPY FOR TREATMENT OF CANCERAug 27, 15Aug 31, 17[A61K, C07K]
2017/0234,854 FRIZZLED-BINDING AGENTS AND USES THEREOFDec 19, 16Aug 17, 17[G01N]
2017/0218,041 Wnt Antagonists and Methods of Treatment and ScreeningJan 13, 17Aug 03, 17[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914771 Method for making heteromultimeric moleculesMar 03, 16Mar 13, 18[A61K, C12N, C07K]
9879084 Modified immunoglobulin molecules that specifically bind human VEGF and DLL4Jan 09, 17Jan 30, 18[A61K, C12P, C07K]
9873726 Methods for identifying and isolating cells expressing a polypeptideJul 14, 16Jan 23, 18[C12N, G01N, C07K]
9850311 Compositions and methods for diagnosing and treating cancerOct 31, 06Dec 26, 17[A61K, C07K]
9833500 Immunotherapy with binding agentsApr 01, 16Dec 05, 17[A61K, C07K]
9732139 Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptorNov 30, 15Aug 15, 17[A61K, G01N, C07K]
9724390 Tumor necrosis factor receptor soluble factor binding (TNFRSF-binding) agentsFeb 03, 16Aug 08, 17[A61K, C12Q, C12N, C07K]
9717794 Compositions and methods for treating and diagnosing cancerApr 22, 15Aug 01, 17[A61K, C07K]
9676865 Antibodies to a non-ligand binding region of at least two NOTCH receptorsJun 18, 14Jun 13, 17[A61K, A61N, C07K]
9644034 Anti-RSPO2 antibodies and uses thereofJul 09, 15May 09, 17[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0198,031 NOTCH BINDING AGENTS AND ANTAGONISTS AND METHODS OF USE THEREOFAbandonedOct 20, 16Jul 13, 17[A61K, C07K]
2017/0183,405 NOTCH1 RECEPTOR BINDING AGENTS AND METHODS OF USE THEREOFAbandonedOct 12, 16Jun 29, 17[A61K, A61N, C07K]
2016/0334,423 METHODS AND MONITORING OF TREATMENT WITH A DLL4 ANTAGONISTAbandonedMar 15, 16Nov 17, 16[A61K, G01N, C07K]
2016/0324,961 Methods for Treating Cancer with DLL4 AntagonistsAbandonedApr 13, 16Nov 10, 16[A61K]
2016/0319,034 MET-BINDING AGENTS AND USES THEREOFAbandonedMar 12, 14Nov 03, 16[A61K, C12Q, G01N, C07K]
2016/0243,223 METHODS FOR TREATING CANCERS COMPRISING K-RAS MUTATIONSAbandonedDec 08, 15Aug 25, 16[A61K]
2016/0137,744 MET-BINDING AGENTS AND USES THEREOFAbandonedSep 14, 15May 19, 16[C07K]
2016/0030,561 Methods of Treating Pancreatic CancerAbandonedMar 13, 14Feb 04, 16[A61K, C12Q, G01N, C07K]
2015/0368,329 Methods of Treating Ocular DiseasesAbandonedOct 15, 13Dec 24, 15[C07K]
2015/0316,552 Human Notch Receptor Mutations and Their UseAbandonedNov 14, 12Nov 05, 15[A61K, C12Q, G01N, C07K]
2015/0232,570 Methods of Treating Hematological Malignancies with Notch1 AntibodiesAbandonedSep 20, 13Aug 20, 15[A61K, C12Q, C07K]
2015/0132,301 Combination Therapy for Treatment of CancerAbandonedDec 07, 12May 14, 15[A61K]
2014/0227,252 Methods and Monitoring of Treatment with a DLL4 AntagonistAbandonedOct 31, 13Aug 14, 14[A61K, G01N, C07K]
2014/0186,342 Compositions and Methods for Diagnosing and Treating CancerAbandonedJan 06, 14Jul 03, 14[A61K, C07K]
2014/0056,890 Binding Agents That Modulate the Hippo Pathway and Uses ThereofAbandonedJun 06, 13Feb 27, 14[A61K, C07K]
2014/0030,786 COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCERAbandonedJul 11, 13Jan 30, 14[C12N]
2013/0323,265 METHODS FOR TREATING CANCER WITH DLL4 ANTAGONISTSAbandonedNov 15, 11Dec 05, 13[A61K]
2013/0323,266 METHODS FOR TREATING CANCER WITH NOTCH2/3 ANTIBODIESAbandonedMay 16, 13Dec 05, 13[A61K]
2013/0316,450 Compositions and Methods for Diagnosing and Treating CancerAbandonedMay 10, 13Nov 28, 13[C07K]
2013/0295,106 Frizzled-Binding Agents And Uses ThereofAbandonedMar 13, 13Nov 07, 13[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.